Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Phase II Trial Comparing Pazopanib With Doxorubicin as First Line Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma

NCT01861951 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT01861951
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01861951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Phase II Trial Comparing Pazopanib With Doxorubicin as First Line Treatment in Elderly Patients With Metastatic or Advanced Soft Tissue Sarcoma
Lead sponsor
Hannover Medical School
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2012
Completion date
July 11, 2017
Enrollment
120 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

soft tissue sarcoma